Evaluation of Atomoxetine on stuttering of childre
Phase 3
Recruiting
- Conditions
- Stuttering.stutteringF98.5
- Registration Number
- IRCT20190717044247N1
- Lead Sponsor
- Ardabil University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
All 4 to 12 year-old patients with stuttering.
Exclusion Criteria
Patients aged 12 to 4 years with stuttering with brain or evolutionary problems.
Patients aged 4 to 12 years with stuttering do not go on a three-month follow-up to continue treatment.
Patients aged 4 to 12 years with stutter, who are treated with a drug other than atomextin.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Stuttering severity. Timepoint: Beginning of intervention and end of the 3 month period. Method of measurement: Severity Measurement Tool SSI4.
- Secondary Outcome Measures
Name Time Method